Xu H - Search Results

1

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies.

Wang L, Xu H, Wu Y. Wang L, et al. Among authors: xu h. Front Oncol. 2023 Feb 10;13:1154661. doi: 10.3389/fonc.2023.1154661. eCollection 2023. Front Oncol. 2023. PMID: 36845689 Free PMC article. No abstract available.

2

Secondary Bile Acids and Tumorigenesis in Colorectal Cancer.

Liu Y, Zhang S, Zhou W, Hu D, Xu H, Ji G. Liu Y, et al. Among authors: xu h. Front Oncol. 2022 Apr 28;12:813745. doi: 10.3389/fonc.2022.813745. eCollection 2022. Front Oncol. 2022. PMID: 35574393 Free PMC article. Review.

3

Can Natural Products be Used to Overcome the Limitations of Colorectal Cancer Immunotherapy?

Dong J, Qian Y, Zhang G, Lu L, Zhang S, Ji G, Zhao A, Xu H. Dong J, et al. Among authors: xu h. Front Oncol. 2022 May 4;12:884423. doi: 10.3389/fonc.2022.884423. eCollection 2022. Front Oncol. 2022. PMID: 35600371 Free PMC article. Review.

4

Can proline dehydrogenase-a key enzyme involved in proline metabolism-be a novel target for cancer therapy?

Xu X, Zhang G, Chen Y, Xu W, Liu Y, Ji G, Xu H. Xu X, et al. Among authors: xu w, xu h. Front Oncol. 2023 Nov 6;13:1254439. doi: 10.3389/fonc.2023.1254439. eCollection 2023. Front Oncol. 2023. PMID: 38023181 Free PMC article. Review.

5

RNA-Seq profiling of circular RNAs in human colorectal cancer 5-fluorouracil resistance and potential biomarkers.

Cheng PQ, Liu YJ, Zhang SA, Lu L, Zhou WJ, Hu D, Xu HC, Ji G. Cheng PQ, et al. World J Gastrointest Oncol. 2022 Mar 15;14(3):678-689. doi: 10.4251/wjgo.v14.i3.678. World J Gastrointest Oncol. 2022. PMID: 35321280 Free PMC article.

6

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products.

Shao G, Liu Y, Lu L, Zhang G, Zhou W, Wu T, Wang L, Xu H, Ji G. Shao G, et al. Among authors: xu h. Front Pharmacol. 2022 Jul 7;13:944088. doi: 10.3389/fphar.2022.944088. eCollection 2022. Front Pharmacol. 2022. PMID: 35873545 Free PMC article. Review.

7

New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer.

Lu L, Dong J, Liu Y, Qian Y, Zhang G, Zhou W, Zhao A, Ji G, Xu H. Lu L, et al. Among authors: xu h. Front Pharmacol. 2022 Aug 15;13:964793. doi: 10.3389/fphar.2022.964793. eCollection 2022. Front Pharmacol. 2022. PMID: 36046819 Free PMC article. Review.

8

A strategy for the treatment of gastrointestinal cancer: Targeting tumor senescent cells.

Liu Y, Zhang Q, Ni W, Ji G, Xu H. Liu Y, et al. Among authors: xu h. Front Mol Biosci. 2023 Mar 6;10:1139840. doi: 10.3389/fmolb.2023.1139840. eCollection 2023. Front Mol Biosci. 2023. PMID: 36950520 Free PMC article. Review.

9

Acacetin exerts antitumor effects on gastric cancer by targeting EGFR.

Zhang G, Dong J, Lu L, Liu Y, Hu D, Wu Y, Zhao A, Xu H. Zhang G, et al. Among authors: xu h. Front Pharmacol. 2023 May 17;14:1121643. doi: 10.3389/fphar.2023.1121643. eCollection 2023. Front Pharmacol. 2023. PMID: 37266143 Free PMC article.

10

Drug resistance and new therapies in colorectal cancer.

Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G. Van der Jeught K, et al. World J Gastroenterol. 2018 Sep 14;24(34):3834-3848. doi: 10.3748/wjg.v24.i34.3834. World J Gastroenterol. 2018. PMID: 30228778 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42,034 results

Search Page